Patients JP Morgan 2023 – Fred Turner Fred Turner is CEO of Curative, a company that’s just announced a head-scratching pivot: from COVID-testing company to large-group commercial health plan.
News Another LAG-3 setback as Regeneron drug fails phase 3 trial Regeneron's LAG-3 inhibitor fianlimab has missed the mark in a highly anticipated melanoma trial, hitting its share price.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
